|
Dec 29
|
Neurological and obesity drugs will be prevalent in 2024
|
|
Dec 28
|
The Zacks Analyst Blog Highlights Novo Nordisk, Walmart, Advanced Micro Devices, Caterpillar and Union Pacific
|
|
Dec 28
|
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
|
|
Dec 28
|
Novo Nordisk (NVO) Rose on Increased Demand
|
|
Dec 27
|
Top Analyst Reports for Novo Nordisk, Walmart & AMD
|
|
Dec 27
|
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024
|
|
Dec 27
|
Healthcare Stocks Had a Terrible 2023. Things Are Looking Up.
|
|
Dec 26
|
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
|
|
Dec 23
|
Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?
|
|
Dec 22
|
FDA warns Americans about fake Ozempic
|
|
Dec 22
|
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
|
|
Dec 22
|
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
|
|
Dec 22
|
Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due
|
|
Dec 21
|
UPDATE 2-US FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
|
|
Dec 21
|
Universal Health (UHS) Up 17% in 3 Months: More Growth Ahead?
|
|
Dec 21
|
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
|
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
|
Dec 21
|
Looking to Invest in the Next Big Craze Like Ozempic? This 1 Emerging Field Could Be It.
|
|
Dec 21
|
Novo Nordisk A/S (NVO) Reported a Strong Third Quarter
|
|
Dec 20
|
Why Novo Nordisk Stock Was Up on a Down Day for the Market
|